The authors precisely Notice The dearth of randomized managed trials for orthopaedic indications—meaning we could’t confidently say it really works, what the actual facet-effect profile is, or what a “safe dose” will be in the true environment (systematic assessment, 2024).If the goal is “fewer downtime, a lot more training,” there’s